Dr. David Haddow, Operations Director of Altrika, delivered a keynote speech at the Regener8 Annual Meeting on 29th September. As one of the leading Regenerative Medicine industry networks in the UK, Regener8 brings together a wide range of academic, research and commercial organisations covering the full extent of activities in the field.
Dr. Haddow’s talk, entitled “The development and production of biomaterials and advanced surfaces for regenerative therapies”, covered the development of Altrika’s Myskin and Cryoskin cell therapy products and highlighted a number of the lessons learnt on the journey from the lab bench to market, as well as outlining some current development projects utilising Altrika’s materials discovery platform.
For more details of the organisation and Dr. Haddow’s speech, please follow the following link:
http://content.yudu.com/Library/A1u6bm/regenMagazineSeptemb/resources/index.htm?referrerUrl=http%3A%2F%2Fwww.yudu.com%2Fitem%2Fdetails%2F415238%2Fregen-Magazine-September-2011%3Frefid%3D121005